Correction: The key cellular senescence related molecule RRM2 regulates prostate cancer progression and resistance to docetaxel treatment

Antzeko izenburuak

• The key cellular senescence related molecule RRM2 regulates prostate cancer progression and resistance to docetaxel treatment
  nork: Bisheng Cheng, et al.
  Argitaratua: (2023-11-01)
• Single-cell deconvolution algorithms analysis unveils autocrine IL11-mediated resistance to docetaxel in prostate cancer via activation of the JAK1/STAT4 pathway
  nork: Bisheng Cheng, et al.
  Argitaratua: (2024-03-01)
• Correction: Single-cell deconvolution algorithms analysis unveils autocrine IL11-mediated resistance to docetaxel in prostate cancer via activation of the JAK1/STAT4 pathway
  nork: Bisheng Cheng, et al.
  Argitaratua: (2024-12-01)
• Recent Developments in Small-Molecule Fluorescent Probes for Cellular Senescence
  nork: Junyoung Park, et al.
  Argitaratua: (2024-07-01)
• Bevacizumab and Weekly Docetaxel in Patients with Metastatic Castrate-Resistant Prostate Cancer Previously Exposed to Docetaxel
  nork: Filippo Francini, et al.
  Argitaratua: (2011-01-01)